US Patent Issued to Ablynx on Dec. 9 for "Antigen binding dimer-complexes, methods of making/avoiding and uses thereof" (Belgian Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,239, issued on Dec. 9, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium).

"Antigen binding dimer-complexes, methods of making/avoiding and uses thereof" was invented by Ann Brige (Ertvelde, Belgium), Christine Labeur (Bruges, Belgium) and Marc Jozef Lauwereys (Haaltert, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "In a broad aspect the present invention generally relates to novel dimer-complexes (herein called "non-fused-dimers" or NFDs) comprising single variable domains, methods of making these complexes and uses thereof. These non-covalently bound dimer-complexes consist of two identical monomers that each comprises of one or more ...